β-adrenergic relaxation in pulmonary arteries: Preservation of the endothelial nitric oxide-dependent β2 component in pulmonary hypertension

Cardiovascular Research

Volumn 77, Issue 1, 2008, Pages 202-210

  Leblais, Véronique ^a,b   Delannoy, Estelle ^a,b   Fresquet, Fleur ^a,b   Bégueret, Hugues ^c   Bellance, Nadège ^a,b   Banquet, Sébastien ^a,b   Allières, Cécile ^d   Leroux, Lionel ^d   Desgranges, Claude ^d   Gadeau, Alain ^d   Muller, Bernard ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d INSERM   (France)

Author keywords

Adrenergic; Endothelial function; Hypoxia; Nitric oxide; Pulmonary

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ACETYLCHOLINE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYANOPINDOLOL; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROCATEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG TARGETING; ENZYME ACTIVITY; GENE DELETION; HEART HEMODYNAMICS; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG CIRCULATION; MALE; MOUSE; MUSCLE RELAXATION; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION;

ANIMALS; ANOXIA; CHRONIC DISEASE; ENDOTHELIUM, VASCULAR; HYPERTENSION, PULMONARY; MALE; MICE; MICE, INBRED C57BL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PULMONARY ARTERY; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-2; VASODILATION;

EID: 38849137975     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm008     Document Type: Article

References (39)

1. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2003;21:892-905.
2. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:13S-24S.
3. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109:159-165.
4. Li H, Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol 2000;190:244-254.
5. Gewaltig MT, Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 2002;55:250-260.
6. Kuriyama H, Ito Y, Suzuki H, Kitamura K, Itoh T. Factors modifying contraction-relaxation cycle in vascular smooth muscles. Am J Physiol Heart Circ Physiol 1982;243:H641-H662.
7. Gray DW, Marshall I. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol 1992;107:684-690.
8. Graves J, Poston L. Beta-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br J Pharmacol 1993;108:631-637.
9. Ferro A, Coash M, Yamamoto T, Rob J, Ji Y, Queen L. Nitric oxidedependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt. Br J Pharmacol 2004;143:397-403.
10. Bea ML, Ghaleh B, Giudicelli JF, Berdeaux A. Lack of importance of NO in beta-adrenoceptor-mediated relaxation of large epicardial canine coronary arteries. Br J Pharmacol 1994;111:981-982.
11. Eckly AE, Stoclet JC, Lugnier C. Isoprenaline induces endothelium-independent relaxation and accumulation of cyclic nucleotides in the rat aorta. Eur J Pharmacol 1994;271:237-240.
12. Trochu JN, Leblais V, Rautureau Y, Beverelli F, Le Marec H, Berdeaux A et al. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol 1999;128:69-76.
13. Barnes PJ, Liu SF. Regulation of pulmonary vascular tone. Pharmacol Rev 1995;47:87-131.
14. Priest RM, Hucks D, Ward JP. Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat. Br J Pharmacol 1997;122:1375-1384.
15. Priest RM, Robertson TP, Leach RM, Ward JP. Membrane potential-dependent and -independent vasodilation in small pulmonary arteries from chronically hypoxic rats. J Pharmacol Exp Ther 1998;285:975-982.
16. Pourageaud F, Leblais V, Bellance N, Marthan R, Muller B. Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery. Naunyn Schmiedebergs Arch Pharmacol 2005;372:14-23.
17. Chruscinski A, Brede ME, Meinel L, Lohse MJ, Kobilka BK, Hein L. Differential distribution of beta-adrenergic receptor subtypes in blood vessels of knockout mice lacking beta(1)- or beta(2)-adrenergic receptors. Mol Pharmacol 2001;60:955-962.
18. Fresquet F, Pourageaud F, Leblais V, Brandes RP, Savineau JP, Marthan R et al. Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br J Pharmacol 2006;148:714-723.
19. Gödecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon HJ, Gödecke S et al. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 1998;82:186-194.
20. Leblais V, Pourageaud F, Ivorra MD, Guibert C, Marthan R, Muller B. Role of alpha-adrenergic receptors in the effect of the beta-adrenergic receptor ligands, CGP 12177, bupranolol, and SR 59230A, on the contraction of rat intrapulmonary artery. J Pharmacol Exp Ther 2004;309:137-145.
21. Bryan RM Jr, Steenberg ML, Eichler MY, Johnson TD, Swafford MW, Suresh MS. Permissive role of NO in alpha 2-adrenoceptor-mediated dilations in rat cerebral arteries. Am J Physiol Heart Circ Physiol 1995; 269:H1171-H1174.
22. Candelore MR, Deng L, Tota L, Guan XM, Amend A, Liu Y et al. Potent and selective human beta(3)-adrenergic receptor antagonists. J Pharmacol Exp Ther 1999;290:649-655.
23. Mallem MY, Toumaniantz G, Serpillon S, Gautier F, Gogny M, Desfontis JC et al. Impairment of the low-affinity state beta1-adrenoceptor-induced relaxation in spontaneously hypertensive rats. Br J Pharmacol 2004;143:599-605.
24. Zheng M, Zhu W, Han Q, Xiao RP. Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling. Pharmacol Ther 2005;108:257-268.
25. Scotland RS, Madhani M, Chauhan S, Moncada S, Andresen J, Nilsson H et al. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 2005;111:796-803.
26. Queen LR, Ji Y, Xu B, Young L, Yao K, Wyatt AW et al. Mechanisms underlying beta2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells. J Physiol 2006;576:585-594.
27. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003;284:R1-R12.
28. Thorin E, Huang PL, Fishman MC, Bevan JA. Nitric oxide inhibits alpha2-adrenoceptor-mediated endothelium-dependent vasodilation. Circ Res 1998;82:1323-1329.
29. Bubikat A, De Windt LJ, Zetsche B, Fabritz L, Sickler H, Eckardt D et al. Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice. J Biol Chem 2005;280:21594-21599.
30. Cook S, Vollenweider P, Menard B, Egli M, Nicod P, Scherrer U. Increased eNO and pulmonary iNOS expression in eNOS null mice. Eur Respir J 2003; 21:770-773.
31. Fagan KA, Tyler RC, Sato K, Fouty BW, Morris KG Jr, Huang PL et al. Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation. Am J Physiol Lung Cell Mol Physiol 1999;277:L472-L478.
32. Miller AA, Hislop AA, Vallance PJ, Haworth SG. Deletion of the eNOS gene has a greater impact on the pulmonary circulation of male than female mice. Am J Physiol Lung Cell Mol Physiol 2005;289:L299-L306.
33. Dumitrascu R, Weissmann N, Ghofrani HA, Dony E, Beuerlein K, Schmidt H et al. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 2006;113:286-295.
34. Li D, Zhou N, Johns RA. Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxia. Am J Physiol Lung Cell Mol Physiol 1999;277:L841-L847.
35. Jernigan NL, Walker BR, Resta TC. Pulmonary PKG-1 is upregulated following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2003;285:L634-L642.
36. Jernigan NL, Walker BR, Resta TC. Chronic hypoxia augments protein kinase G-mediated Ca2+ desensitization in pulmonary vascular smooth muscle through inhibition of RhoA/Rho kinase signaling. Am J Physiol Lung Cell Mol Physiol 2004;287:L1220-L1229.
37. Vercauteren M, Remy E, Devaux C, Dautreaux B, Henry JP, Bauer F et al. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation 2006;114: 2498-2507.
38. Sarr M, Chataigneau M, Martins S, Schott C, El Bedoui J, Oak MH et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res 2006;71:794-802.
39. Cazzola M, Mantero A, Santus P, Carlucci P, Mondoni M, Bosotti L et al. Doppler echocardiographic assessment of the effects of inhaled long-acting beta(2)-agonists on pulmonary artery pressure in COPD patients. Pulm Pharmacol Ther 2007;20:258-264.